All News
ACR20 – Day 1 Report
Friday was the first full day of scientific sessions at the 2020 Virtual ACR/ARP annual meeting. Here are my highlights from day one:
Read Article
Severe manifestations in #COVID19 infection. Dr Fauci #ACR20 @RheumNow Cytokine storm ⚡️⚡️⛈🌩 https://t.co/qsFjjP5iKG
Sole RetamozoSole ( View Tweet)
“We remain cautiously optimistic that we will have a safe, effective vaccine based on animal studies.” Here is an up-to-date list of COVID-19 trials as discussed at #ACR20 by Dr. A. Fauci @RheumNow https://t.co/DAoLGGtw1A
Dr. Rachel Tate uptoTate ( View Tweet)
Fauci: Common endpoints, common parameters provide "bridge" between #COVID19 vaccine trials. "We are cautiously optimistic" for a vaccine "by the end of the calendar year" because of favorable animal studies, though distribution will be later #ACR20 @Rheumnow. https://t.co/vPLEYiGKam
Eric Dein ejdein1 ( View Tweet)
A reminder or the fundamentals to curbing COVID19 per Dr. Anthony Fauci at #ACR20:
1. Everyone needs to wear a mask
2. Maintain 6 feet distance from others
3. Avoid crowds & congregations
4. Outdoor better than indoors
5. Wash your hands frequently
@RheumNow @LCalabreseDO https://t.co/khLS7V2A3b
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
“If we follow these five fundamentals we will not see the surging (of COVID-19)” Dr. Fauci #ACR20 @RheumNow https://t.co/dcPUmvUdcc
Dr. Rachel Tate uptoTate ( View Tweet)
The one time at #ACR20 that only one sceen is on! #LTF @FauciFan @RheumNow so much respect for Dr Fauci! https://t.co/jhvlc8Py7R
Bella Mehta bella_mehta ( View Tweet)
Tracking CRP in the hyper-acute phase of admission for #COVID19 predictive of progression to critical illness- suggests trends of inflammatory biomarkers, not absolute admission values, may be most useful for triage & therapy.
Abs#0626 #ACR20 @RheumNow
https://t.co/E14y3e4ALi
Mrinalini Dey DrMiniDey ( View Tweet)
Consistent data that antimalarials did NOT decrease hospitalization for viral infections in the pre #COVID19 era in US claims database in SLE &RA pts #0002 @RheumNow @CRASCRRheum #ACR20 #ACR2020 https://t.co/nZp5dOeHXB
Janet Pope Janetbirdope ( View Tweet)
#COVID19 outcomes in systematic autoimmune diseases N=716 Pop’n matched by age & sex other COVID pts. Glass is half empty. More hospitalization, ICU, ventilation but death 5% v 4.3%. Abstr#430 #ACR20 @RheumNow @CRASCRRheum https://t.co/cqko0Igd8L
Janet Pope Janetbirdope ( View Tweet)
Should we in rheumatology be the ones leading the trials using our drugs with checkpoint inhibitors?
Can we learn lessons about collaborative work from @rheum_covid?
Provoking questions for the new challenges in treatment of irAEs! https://t.co/chl8TeOoMy
David Liew drdavidliew ( View Tweet)
Great talk by @rheumcat @rheum_covid on COVID-19 impact on rheumatology. Talk to pts re: what to do with rheum rx... they haven't read guidelines and may make their own changes! Prepare them for exposure/ifn! #ACR20 @Rheumnow 2F042 https://t.co/HkxbkYjEm3
Eric Dein ejdein1 ( View Tweet)
Another study on rheum pt outcomes w/#COVID19: similar outcomes as nonrheum pts. MGH/JHU/Brigham 143 rheum vs 688 nonrheum. No⬆️risk in rheums after adjusting for race/smoking/comorbidities for: hospitalizations, mech ventil'n 3. ICU 4. death #ACR20 Abstr#L01 @RheumNow https://t.co/362UZUe5dg
k dao KDAO2011 ( View Tweet)
Dr. Phillips touches on a few things to consider how teleheath has changed the delivery of care due to COVID-19. Planning your post-pandemic business strategy, due demand for our specialty, is important. #ACR20 @RheumNow https://t.co/A2dsVy1KSg
Dr. Rachel Tate uptoTate ( View Tweet)
Highlighting results from @rheum_covid at #ACR20
Race/ethnicity Associated with Poor Outcomes in #RheumaticDisease Patients with #COVID19 by @MilenaGianfran et al
Abstract #0006👉https://t.co/13jsl8BjcH
Full paper👉https://t.co/Qeo0dOoIOQ
@RheumNow
https://t.co/U9cgaYYaOj
Links:
Mrinalini Dey DrMiniDey ( View Tweet)
#ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity and vaccines in #COVID19. Many post covid inflammatory symptoms but not sure if its because of background autoimmunity. Need more data. More to come in a few months @RheumNow
Bella Mehta bella_mehta ( View Tweet)
Eric Rubin, MD, editor-in-chief @NEJM #ACR20 discusses how New Zealand can have large rugby matches by intervening before infection occurs. #LTF, @RheumNow.
Eric Dein ejdein1 ( View Tweet)
Reminder of the glucocorticoids (GC) paradigm: don’t use them early during viral replication as morbidity and mortality (M&M) can increase with early use! But GCs CAN prevent the late complications that cause M&M when used at the appropriate time point. #ACR20 @RheumNow https://t.co/l2e0J1nANd
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
The GRA now have >17,000 pts registered! Watch the video link @rheumnow or YouTube: https://t.co/tdp5q7tAPK
Please visit the GRA booth @rheum_cat @JYazdanyMD @philipcrobinson @rheum_covid #ACR20 https://t.co/UObvGO3n9Q
Links:
k dao KDAO2011 ( View Tweet)
Where one lives matters! Especially during the #COVID19 "flares" - Geographical variations in risk perception and medication management by rheumatologists vary by #COVID19 case burden in the community. Check our abst#0005 #ACR20 @RheumNow
Bella Mehta bella_mehta ( View Tweet)
